The never-ending enigma of immune thrombocytopenia
Open Access
- 18 June 2020
- journal article
- editorial
- Published by American Society of Hematology in Blood
- Vol. 135 (25), 2207-2209
- https://doi.org/10.1182/blood.2020005555
Abstract
In this issue of Blood, Morodomi et al advance our understanding of the mechanisms involved in antibody-mediated immune thrombocytopenia (ITP).(1)This publication has 11 references indexed in Scilit:
- Macrophage galactose lectin is critical for Kupffer cells to clear aged plateletsThe Journal of Experimental Medicine, 2020
- Immune ThrombocytopeniaThe New England Journal of Medicine, 2019
- Pathophysiology of immune thrombocytopeniaCurrent Opinion in Hematology, 2018
- Clinical updates in adult immune thrombocytopeniaBlood, 2017
- Pathogenesis and Therapeutic Mechanisms in Immune Thrombocytopenia (ITP)Journal of Clinical Medicine, 2017
- Faculty Opinions recommendation of Desialylation is a mechanism of Fc-independent platelet clearance and a therapeutic target in immune thrombocytopenia.Published by H1 Connect ,2016
- Desialylation is a mechanism of Fc-independent platelet clearance and a therapeutic target in immune thrombocytopeniaNature Communications, 2015
- The Ashwell-Morell receptor regulates hepatic thrombopoietin production via JAK2-STAT3 signalingNature Medicine, 2014
- Severe platelet desialylation in a patient with glycoprotein Ib/IX antibody-mediated immune thrombocytopenia and fatal pulmonary hemorrhageHaematologica, 2014
- Autoantibody‐mediated complement activation on platelets is a common finding in patients with immune thrombocytopenic purpura (ITP)European Journal of Haematology, 2011